Can Vraylar (cariprazine) tablets be split?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Vraylar Tablets Be Split?

No, Vraylar (cariprazine) capsules should not be split or opened. Vraylar is manufactured exclusively as intact capsules that must be swallowed whole.

Formulation Details

Vraylar is available only in capsule form in six strengths: 0.5 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, and 6 mg 1. The capsule formulation is designed to deliver precise dosing and cannot be divided, crushed, or opened.

Dosing Flexibility Without Splitting

While the capsules cannot be split, the manufacturer provides multiple capsule strengths specifically to allow flexible dosing without the need for splitting:

  • For dose adjustments, prescribers can select from the six available strengths to achieve the desired dose
  • For titration, the 0.5 mg and 0.75 mg capsules enable gradual dose increases, particularly important when:
    • Starting therapy in pediatric patients (0.5 mg starting dose) 1
    • Adjusting doses in patients taking CYP3A4 inhibitors (may require 0.5 mg or 0.75 mg doses) 1

Clinical Implications

The inability to split cariprazine capsules has been recognized as a practical challenge during dose titration, as it prevents dose increases smaller than 1.5 mg increments when using only the higher-strength capsules 2. However, this limitation is addressed by:

  • Using the lower-strength capsules (0.5 mg, 0.75 mg) for fine-tuned adjustments
  • Following the manufacturer's structured titration schedules that account for the available capsule strengths
  • Understanding that cariprazine's long half-life (approximately 1 week for 50% decline in active drug and metabolites) means dose changes are not immediately reflected in clinical response 1

The capsule formulation must be taken intact as prescribed, and dose adjustments should be made by switching to different capsule strengths rather than attempting to split or modify the capsules.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.